Are You Missing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD)?

Research developments in MOGADПодробнее

MOGAD (Myelin Oligodendrocyte Glycoprotein Associated Disease) Explained by NeurologistПодробнее

Proposed criteria for the diagnosis of MOGADПодробнее

Predicting relapses in MOGADПодробнее

Analysis of the diagnostic utility of cerebrospinal fluid MOG-IgGПодробнее

The pathology of MS and MOGAD: similarities and differencesПодробнее

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological studyПодробнее

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)Подробнее

MS & MOGAD: differences in response to immunomodulatory therapiesПодробнее

2022 Pre-RNDS | MOG Antibody Disease (MOGAD)Подробнее

MOG and Neuromyelitis OpticaПодробнее

Myelin Oligodendrocyte Glycoprotein (MOG)Подробнее

What is MOG Antibody Disease? (MOGAD)Подробнее

Significance of MOG Antibodies in CSFПодробнее

Demyelinating disorders: Impact of a novel biomarker on clinical practiceПодробнее

2021 RNDS | MOG Antibody Disease (MOGAD)Подробнее

Current MOGAD criteria and the role of MRI in diagnosisПодробнее

205. MOGAD and NMOSD: Is MOGAD Part of NMOSD or a Distinct Diagnosis?Подробнее

2020 RNDS | What is MOG Antibody Disease (MOGAD)?Подробнее